A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine.
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication alleviates symptoms of major depression in as little as a few hours.
UB researchers have received a $$3.28 million grant from the NIH to investigate the use of structured financial incentives in lowering cardiovascular disease (CVD) risk among African Americans facing food insecurity.
A paper published today explains why there needs to be a shift in cannabis policies to a public health approach as opposed to the prevailing, more punitive approach that pushes abstinence instead of public education.
UB research that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
UB's new Aging and Resilience Research Center on The Brothers of Mercy Wellness Campus in Clarence, N.Y. is dedicated to identifying the factors that contribute to healthy, resilient aging.
A research leader in systems pharmacology and pharmacodynamics, Mager will be recognized Sunday, Nov. 10, during the 2024 American Conference on Pharmacometrics at the Arizona Grand Resort and Spa in Phoenix.
L. Nelson “Nick” Hopkins, MD, SUNY Distinguished Professor and a neurosurgeon best known for changing the way stroke patients are treated, died Oct. 5. He was 81.
Elad Levy will present results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis at the Congress of Neurological Surgeons (CNS).
UB research has identified the genetic elements responsible for turning classical Klebsiella pneumoniae into a hypervirulent version, which can infect otherwise healthy people in the community.
Daniel Woo, MD, professor of neurology and rehabilitation medicine in the University of Cincinnati College of Medicine, has been appointed the Irvin and Rosemary Smith Endowed Chair of the Department of Neurology.
A UB psychiatrist who has played a critical role in getting mental health screening and treatment integrated into routine care for cystic fibrosis (CF) has been awarded $3 million from the Cystic Fibrosis Foundation to focus on the mental health of children with the disease.
Michael Oldani, PhD, director of interprofessional practice and education at Concordia University Wisconsin and professor in its School of Pharmacy, has been appointed executive director for interprofessional education (IPE) at UB.
Elad I. Levy, MD, SUNY Distinguished Professor and the L. Nelson Hopkins Endowed Chair of the Department of Neurosurgery, has been awarded the Ralph G. Dacey, Jr. Medal for Outstanding Cerebrovascular Research.
